165 related articles for article (PubMed ID: 31768798)
21. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
[TBL] [Abstract][Full Text] [Related]
22. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
[TBL] [Abstract][Full Text] [Related]
23. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
[TBL] [Abstract][Full Text] [Related]
24. Genomics Study of Gastric Cancer and Its Molecular Subtypes.
Yuen ST; Leung SY
Adv Exp Med Biol; 2016; 908():419-39. PubMed ID: 27573784
[TBL] [Abstract][Full Text] [Related]
25. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer.
Moridnia A; Tabatabaiefar MA; Zeinalian M; Minakari M; Kheirollahi M; Moghaddam NA
J Gastrointest Cancer; 2019 Sep; 50(3):420-427. PubMed ID: 29577179
[TBL] [Abstract][Full Text] [Related]
26. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
27. High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer.
Kim S; Lee J; Hong ME; Do IG; Kang SY; Ha SY; Kim ST; Park SH; Kang WK; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S; Kim DH; Kim KM
PLoS One; 2014; 9(11):e111693. PubMed ID: 25372287
[TBL] [Abstract][Full Text] [Related]
28. Precision medicine in age-specific non-small-cell-lung-cancer patients: Integrating biomolecular results into clinical practice-A new approach to improve personalized translational research.
VavalĂ T; Monica V; Lo Iacono M; Mele T; Busso S; Righi L; Papotti M; Scagliotti GV; Novello S
Lung Cancer; 2017 May; 107():84-90. PubMed ID: 27346245
[TBL] [Abstract][Full Text] [Related]
29. Distinction of differentiated type early gastric carcinoma with gastric type mucin expression.
Koseki K; Takizawa T; Koike M; Ito M; Nihei Z; Sugihara K
Cancer; 2000 Aug; 89(4):724-32. PubMed ID: 10951333
[TBL] [Abstract][Full Text] [Related]
30. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
[TBL] [Abstract][Full Text] [Related]
31. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
32. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach.
Liu Z; Wang A; Pu Y; Li Z; Xue R; Zhang C; Xiang X; E JY; Bu Z; Bai F; Ji J
Oncogene; 2021 Sep; 40(38):5705-5717. PubMed ID: 34326469
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Capture and Amplicon-Based Approaches for the Development of a Targeted Next-Generation Sequencing Pipeline to Personalize Lymphoma Management.
Hung SS; Meissner B; Chavez EA; Ben-Neriah S; Ennishi D; Jones MR; Shulha HP; Chan FC; Boyle M; Kridel R; Gascoyne RD; Mungall AJ; Marra MA; Scott DW; Connors JM; Steidl C
J Mol Diagn; 2018 Mar; 20(2):203-214. PubMed ID: 29429887
[TBL] [Abstract][Full Text] [Related]
34. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine.
Kim S; Park C; Ji Y; Kim DG; Bae H; van Vrancken M; Kim DH; Kim KM
J Mol Diagn; 2017 Jan; 19(1):137-146. PubMed ID: 27840062
[TBL] [Abstract][Full Text] [Related]
35. Relationship between Helicobacter pylori tyrosine-phosphorylated CagA-related markers and the development of diffuse-type gastric cancers: a case-control study.
Wada Y; Ito M; Takata S; Tanaka S; Yoshihara M; Chayama K
Digestion; 2010; 82(1):10-7. PubMed ID: 20145403
[TBL] [Abstract][Full Text] [Related]
36. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.
Suh JH; Johnson A; Albacker L; Wang K; Chmielecki J; Frampton G; Gay L; Elvin JA; Vergilio JA; Ali S; Miller VA; Stephens PJ; Ross JS
Oncologist; 2016 Jun; 21(6):684-91. PubMed ID: 27151654
[TBL] [Abstract][Full Text] [Related]
38. Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray.
Wu CM; Lee YS; Wang TH; Lee LY; Kong WH; Chen ES; Wei ML; Liang Y; Hwang TL
Oncol Rep; 2006 Jan; 15(1):57-64. PubMed ID: 16328034
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
40. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes.
Myllykangas S; Junnila S; Kokkola A; Autio R; Scheinin I; Kiviluoto T; Karjalainen-Lindsberg ML; Hollmén J; Knuutila S; Puolakkainen P; Monni O
Int J Cancer; 2008 Aug; 123(4):817-25. PubMed ID: 18506690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]